A large stroke trial has shown that intensive blood pressure lowering after clot removal worsens recovery. The results of the
Day: October 28, 2022
Pandemic-related stress linked with changes in menstrual cycle
Women with high stress related to the COVID-19 pandemic were twice as likely to experience changes in their menstrual cycle
Wearable device study in 88,000 people shows the heart health benefits of more intense physical activity
Increasing physical activity of any intensity is beneficial for health, but new research published today in the European Heart Journal shows that
Exercise testing detects silent cardiovascular dangers common in pediatric cancer survivors
Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems in asymptomatic pediatric cancer survivors that other types
New study sheds light on basic biology of frontotemporal dementia
Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million
‘Prime and spike’ nasal vaccine strategy helps combat COVID
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale
Discovery of endocannabinoid gene mutation leads to identification of new, rare pediatric neurological disease
In a study published in the October 2022 issue of Brain, researchers from Rady Children’s Institute for Genomic Medicine (RCIGM) and
Battery-free, light-powered pacemaker may improve quality of life for heart disease patients
Atrial fibrillation—a form of irregular heartbeat, or arrhythmia—leads to more than 454,000 hospitalizations and nearly 160,000 deaths in the United
Physicians find success treating a child’s case of rare encephalitis
The prognosis for the sick child, who hadn’t responded to standard treatment, was dire. But a team of Rutgers physicians
Experimental monoclonal antibodies show promise against Epstein-Barr virus
A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in